New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an "eSMO Open-Cancer Horizons" Series

Matteo Lambertini, Matthias Preusser, Christoph C. Zielinski

Research output: Contribution to journal › Editorial › peer-review

Keywords

@article{3b215dd0e9a643818ebc58009fa2a1a1,

title = "New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an {"}eSMO Open-Cancer Horizons{"} Series",

keywords = "immunotherapy",

author = "Matteo Lambertini and Matthias Preusser and Zielinski, {Christoph C.}",

year = "2019",

month = jun,

day = "1",

doi = "10.1136/esmoopen-2019-000501",

language = "English",

volume = "4",

journal = "ESMO Open",

issn = "2059-7029",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1

T2 - Introducing an "eSMO Open-Cancer Horizons" Series

AU - Lambertini, Matteo

AU - Preusser, Matthias

AU - Zielinski, Christoph C.

PY - 2019/6/1

Y1 - 2019/6/1

KW - immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=85067459469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067459469&partnerID=8YFLogxK

U2 - 10.1136/esmoopen-2019-000501

DO - 10.1136/esmoopen-2019-000501

M3 - Editorial

AN - SCOPUS:85067459469

VL - 4

JO - ESMO Open

JF - ESMO Open

SN - 2059-7029

M1 - e000501

ER -